AUSTRALIAN SPORTS ANTI-DOPING AUTHORITY 2010:11 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1833-8976

Table of Contents
Letter of transmittal 3
About this report 4
Message from the CEO 10
Organisational overview 15
About ASADA 16
Legislative basis 16
Role and functions 16
Goals 17
Australia’s anti‑doping structure 17
Minister for Sport 18
Australian Sports Anti‑Doping Authority 18
Outcome and program structure 19
Highlights of 2010–11 20
Report on performance 23
Program 1.1 – Deterrence, detection and enforcement 24
Deliverables 24
Key performance indicators 26
Building awareness 28
Communication campaigns 28
Digital marketing 30
Media 32
Printed resources 34
Education 35
Partnerships 38
Assisting sporting organisations 41
Sports forums 41
Liaison with national sporting bodies 42
International engagement 43
Detection 46
National testing and sport operations program 46
Pure Performance programs 48
User-pays tests 48
Long-term storage facility 49
Accreditation of Doping Control Officers and Chaperones 50
Investigations and intelligence 51
Athlete whereabouts 52
Enforcement 54
Athlete counselling service 56
Management and accountability 59
Corporate governance 60
Corporate and operational planning 60
Organisational structure and Senior Executive arrangements 61
Chief Executive Officer 62
Anti‑Doping Programs and Legal Services 62
Operations 62
Governance committees 62
Risk management 63
Ethical standards 65
Internal audits 66
Recordkeeping 66
Quality management 67
External scrutiny 68
Significant developments 68
Decisions and reports 68
Management of human resources 69
Workforce planning 70
Attraction and retention 70
Employment agreements 71
Section 24(1) determinations 71
Non-salary benefits 71
Performance Management System 71
Australia Day medallions 72
Peer recognition 72
Staff consultation 73
Learning and development 73
Workplace diversity 74
Commonwealth Disability Strategy 74
Occupational health and safety 75
Financial information 77
Summary of financial performance 2010–11 78
Grant programs 78
Asset management 78
Purchasing 79
Engagement of consultants and contractors 79
Consultants 79
Competitive tendering and contracting 81
Auditor-General access 81
Exempt contracts 81
Financial statements 83
ASADA Advisory Group 137
Overview 138
Advisory Group members 138
Resources 139
Anti‑Doping Rule Violation Panel 141
Overview 142
ADRVP members 142
Resources 144
Australian Sports Drug Medical Advisory Committee 147
Therapeutic approvals for prohibited substances 148
ASDMAC members 149
Achievements 151
Resources 151
Freedom of information procedures and ASDMAC contact details 151
Appendixes 155
Appendix A: Doping control statistics 2000–01 to 2010–11 156
Appendix B: Publicly announced Anti‑Doping rule violations 2010–11 157
Appendix C: International anti‑doping and doping control 161
Appendix D: Powers of the Minister to give directions to ASADA and the CEO 162
Appendix E: ASADA and CEO functions, powers and delegations 163
CEO’s functions 163
CEO’s powers 164
Appendix F: Staffing statistics at 30 June 2011 165
Appendix G: Occupational health and safety 168
Appendix H: Advertising and market research 169
Appendix I: Ecologically sustainable development and environmental performance 170
Principles of the legislation 170
Measures taken to minimise environmental impact 170
Appendix J: Freedom of information 171
Organisation and functions of ASADA 171
Decision-making powers 171
Authorised freedom of information decision makers 171
Arrangements for consulting external bodies or people 171
Categories of documents 171
Facilities for the public to obtain physical access to ASADA documents 172
Departmental manuals 172
Freedom of information procedures and ASADA contact details 172
Appendix K: Australian Sports Drug Medical Advisory Committee – functions 174
Appendix L: Australian Sports Drug Medical Advisory Committee – Therapeutic Use Exemptions
(TUEs) granted 175
Appendix M: Anti‑Doping Rule Violation Panel – functions 178
Appendix N: Expenses and resources for Outcome 1 179
Appendix O: ASADA Resource Statement 2010–11 180
Abbreviations and glossary 183
List of abbreviations 184
Glossary 186
Indexes 191
Compliance index 192
Alphabetical index 196
List of Figures
Figure 1: Australia’s anti‑doping framework 18
Figure 2: Outcome and program structure 2010–11 19
Figure 3: Number of athletes and support personnel recording anti‑doping rule violations 56
Figure 4: Organisational structure at 30 June 2011 62

List of Tables
Table 1: Program 1.1 qualitative deliverables 24
Table 2: Program 1.1 quantitative deliverables 25
Table 3: Program 1.1 qualitative key performance indicators 26
Table 4: Program 1.1 quantitative key performance indicators 27
Table 5: Online substance searches and visitors 31
Table 6: Education activities undertaken during 2010–11 37
Table 7: Satisfaction with ASADA education 39
Table 8: Anti‑doping tests conducted by ASADA in 2010–11 48
Table 9: Doping control facts and figures 2010–11 51
Table 10: Substances involved in anti‑doping matters 2010–11 54
Table 11: Breakdown of anti‑doping rule violations 2010–11 55
Table 12: Expenditure on new and existing consultancy contracts 2010–11 79
Table 13: Consultancy services let during 2010–11 of $10,000 or more 80
Table 14: ADRVP attendance 2010–11 143
Table 15: ADRVP expenses 2010–11 144
Table 16: ASDMAC members 149
Table 17: ASDMAC expenses 2010–11 151
Table 18: ASDMAC freedom of information statistics 152
Table 19: Doping control statistics 156
Table 20: Publicly announced anti‑doping rule violations 157
Table 21: Entries on Register of Findings 2009–10 where the outcomes were to be advised 160
Table 22: Government-to-government arrangements 161
Table 23: Full-time and part-time staff at 30 June 2011 165
Table 24: Staff by classification groups and location at 30 June 2011 165
Table 25: SES staff at 30 June 2011 165
Table 26: Staff in equal employment opportunity groups at 30 June 2011 166
Table 27: Salary ranges of employees 166
Table 28: Number of staff in the collective agreement or Section 24(1) determinations 167
Table 29: Advertising and market research 169
Table 30: ASADA freedom of information statistics 173
Table 31: Therapeutic use exemptions granted 175
Table 32: Substances and methods approved for therapeutic use 2010–11 177
Table 33: Expenses and resources for Outcome 1 179
Table 34: ASADA Resource Statement 180

AUSTRALIAN SPORTS ANTI-DOPING AUTHORITY 2011:12 ANNUAL REPORT

TABLE OF CONTENTS
Letter of transmittal 3
About this report 4
Message from the CEO 10

Chapter 1: Organisational overview 17
About ASADA 18
Legislative basis 18
Role and functions 18
Goals 19
Australia’s anti‑doping structure 19
Outcome and program structure 21
Highlights of 2011–12 22

Chapter 2: Report on performance 25
Program 1.1 – Deterrence, detection and enforcement 26
Deliverables 26
Key performance indicators 28
Building awareness 30
Digital marketing 30
Communication campaigns 31
Media 32
Printed resources 34
Education 35
Partnerships 38
Assisting sporting organisations 39
Sports forums 39
Liaison with national sporting bodies 39
International engagement 39
Review of the World Anti‑Doping Code 41
Review of draft Prohibited List 41
WADA Symposium for Anti‑Doping Organisations 41
Institute of National Anti‑Doping Organisations (iNADO) 42
International Anti‑Doping Arrangement (IADA) 42
Monitoring Group for the Council of Europe 42
Third Session of the Conference of Parties to the International Convention Against Doping in Sport 43
Oceania Regional Anti‑Doping Organisation (ORADO) 43
International visitors 43
Detection 44
National testing and sport operations program 45
Sample collection 45
Pure Performance programs 45
User‑pays tests 46
Long‑term storage facility 47
Accreditation of Doping Control Officers and Chaperones 47
Investigations and intelligence 48
Athlete whereabouts 48
Enforcement 49
Athlete counselling service 51

Chapter 3: Management and accountability 53
Corporate governance 54
Corporate and operational planning 54
Organisational structure and senior executive arrangements 55
Governance committees 56
Risk management 57
Ethical standards 59
Internal audits 60
Records management 60
Quality management 61
External scrutiny 62
Significant developments 62
Decisions and reports 62
Management of human resources 62
Workforce planning 63
Attraction and retention 63
Employment agreements 63
Section 24(1) determinations 64
Non‑salary benefits 64
Performance management system 64
Australia Day medallion 64
Peer recognition 65
Staff consultation 65
Survey 65
Learning and development 65
Workplace diversity 66
Commonwealth Disability Strategy 66
Work health and safety 67

Chapter 4: Financial information 69
Summary of financial performance 2011–12 70
Grant programs 70
Asset management 70
Purchasing 71
Engagement of consultants and contractors 71
Consultants 71
Competitive tendering and contracting 72
Auditor-General access 72
Exempt contracts 72

Chapter 5: Financial statements 75

Chapter 6: ASADA Advisory Group 129
Overview 130
Members 130
Resources 131

Chapter 7: Anti‑Doping Rule Violation Panel 133
Overview 134
Functions 134
Members 134
Resources 135

Chapter 8: Australian Sports Drug Medical Advisory Committee 137
Overview 138
Functions 138
Clause 5.01 NAD scheme – functions of ASDMAC 138
Therapeutic approvals for prohibited substances 139
Members 139
Resources 141
Therapeutic Use Exemptions granted 141
Freedom of information – ASDMAC 145

Chapter 9: Appendixes 147
Appendix A: Doping control statistics 2001–02 to 2011–12 148
Appendix B: Publicly announced anti‑doping rule violations 2011–12 149
Appendix C: International anti‑doping and doping control 151
Appendix D: Powers of the Minister to give directions to the ASADA CEO 152
Appendix E: ASADA and CEO functions, powers and delegations 153
Appendix F: Staffing statistics at 30 June 2012 155
Appendix G: Work health and safety 157
Appendix H: Advertising and market research 158
Appendix I: Ecologically sustainable development and environmental performance 159
Appendix J: Freedom of information 160
Appendix K: Expenses and resources for Outcome 1 161
Appendix L: ASADA Resource Statement 2011–12 162

Chapter 10: Abbreviations and glossary 165
List of abbreviations 166
Glossary 168
Chapter 11: Indexes 173
Compliance index 174
Alphabetical index 178

LIST OF FIGURES
Figure 1: Australia’s anti‑doping framework 20
Figure 2: Outcome and program structure 2011–12 21
Figure 3: Number of athletes and support personnel recording anti‑doping rule violations 50
Figure 4: Organisational structure at 30 June 2012 56

LIST OF TABLES
Table 1: Program 1.1 qualitative deliverables 26
Table 2: Program 1.1 quantitative deliverables 27
Table 3: Program 1.1 qualitative key performance indicators 28
Table 4: Program 1.1 quantitative key performance indicators 29
Table 5: Education activities undertaken during 2011–12 37
Table 6: Satisfaction with ASADA education 38
Table 7: Anti‑doping tests conducted by ASADA in 2011–12 46
Table 8: Doping control facts and figures 2011–12 47
Table 9: Substances involved in anti‑doping matters 2011–12 49
Table 10: Breakdown of anti‑doping rule violations 2011–12 50
Table 11: Trends in consultancies 71
Table 12: Advisory Group attendance 2011–12 131
Table 13: Advisory Group expenses 2011–12 131
Table 14: ADRVP attendance 2011–12 135
Table 15: ADRVP expenses 2011–12 135
Table 16: ASDMAC members 141
Table 17: ASDMAC expenses 2011–12 141
Table 18: Therapeutic Use Exemptions granted 141
Table 19: Substances and methods approved for therapeutic use 2011–12 144
Table 20: ASDMAC freedom of information statistics 145
Table 21: Doping control statistics 148
Table 22: Publicly announced anti‑doping rule violations 149
Table 23: Entries on Register of Findings 2010–11 where the outcomes were to be advised 150
Table 24: Government‑to‑government arrangements 151
Table 25: Full‑time, part‑time and casual staff at 30 June 2012 155
Table 26: On‑going, non‑ongoing and casual staff by classification groups and location at 30 June 2012 155
Table 27: SES staff at 30 June 2012 155
Table 28: Staff in equal employment opportunity groups at 30 June 2012 156
Table 29: Salary ranges of employees 156
Table 30: Number of staff in the collective agreement or section 24(1) determinations 156
Table 31: Advertising and market research 158
Table 32: ASADA freedom of information statistics 160
Table 33: Expenses and resources for Outcome 1 161
Table 34: ASADA Resource Statement 162

AUSTRALIAN SPORTS ANTI-DOPING AUTHORITY 2012:13 ANNUAL REPORT

TABLE OF CONTENTS
Letter of transmittal 3
About this report 4
Message from the CEO 10

Chapter 1: Organisational overview 17
About ASADA 18
Australia’s anti-doping structure 18
Legislative basis 20
Goals 20
Role and functions 20
Outcome and program structure 21
Highlights of 2012–13 22

Chapter 2: Report on performance 25
Program 1.1 — Deterrence, detection and enforcement 26
Deliverables 26
Key Performance indicators 28
Building awareness 30
Communications channels 30
Communication campaigns 31
Media 32
Printed resources 32
Education 34
Partnerships 37
Assisting sporting organisations 39
International engagement 39
Liaison with World Anti-Doping Agency (WADA) 40
Review of the World Anti-Doping Code 40
Review of WADA Prohibited List 41
WADA Symposium for Anti-Doping Organisations 41
Institute of National Anti-Doping Organisations (iNADO) 42
International Anti-Doping Arrangement (IADA) 42
Monitoring Group for the Council of Europe 42
International conference on the Pharmaceutical Industry and the Fight Against Doping —
New Partnerships for Clean Sport 42
Anti-Doping Norway symposium 42
Regional Anti-Doping Organisations (RADO) 43
International visitors 43
Detection 44
National testing and sport operations program 44
Pure Performance programs 45
User-pays tests 45
Long-term storage facility 46
Accreditation of DCOs and Chaperones 46
Investigations and Intelligence 47
Athlete whereabouts 50
Enforcement 51
Athlete counselling service 53

Chapter 3: Management and accountability 55
Corporate governance 56
Corporate and operational planning 56
Organisational structure and senior executive arrangements 56
Governance committees 57
Risk management 58
Ethical standards 60
Internal audits 61
Records management 61
Quality management 61
External scrutiny 63
Significant developments 63
Decisions and reports 63
Management of human resources 64
Workforce planning 64
Attraction and retention 64
Employment agreements 65
Section 24(1) determinations 65
Non-salary benefits 65
Performance pay 65
Australia Day medallion 65
Survey 66
Learning and development 66
Workplace diversity 67
Commonwealth Disability Strategy 67
Workplace health and safety 67

Chapter 4: Financial information 69
Summary of financial performance 2012–13 70
Asset management 70
Purchasing 71
Engagement of consultants and contractors 71
Consultants 71
Competitive tendering and contracting 72
Auditor-General access 72
Exempt contracts 72
Grant programs 72

Chapter 5: Financial statements 75

Chapter 6: ASADA Advisory Group 127
Overview 128
Advisory Group members 128
Resources 129

Chapter 7: Anti‑Doping Rule Violation Panel 131
Overview 132
Functions 132
Members 132
Resources 134

Chapter 8: Australian Sports Drug Medical Advisory Committee 137
Overview 138
Functions 138
Therapeutic approvals for prohibited substances 139
Members 139
Resources 142
Therapeutic Use Exemptions granted 142
Freedom of information — ASDMAC 145

Chapter 9: Appendixes 147
Appendix A: Doping control statistics 2001–02 to 2012–13 148
Appendix B: Publicly announced anti-doping rule violations 2012–13 149
Appendix C: International anti-doping and doping control 151
Appendix D: Powers of the Minister to give directions to the ASADA CEO 152
Appendix E: ASADA and CEO functions, powers and delegations 153
Appendix F: Staffing statistics at 30 June 2013 154
Appendix G: Workplace health and safety 156
Appendix H: Advertising and market research 157
Appendix I: Ecologically sustainable development and environmental performance 158
Appendix J: Freedom of information 159
Appendix K: Expenses for Outcome 1 160
Appendix L: ASADA Resource Statement 2012–13 161

Chapter 10: Abbreviations and glossary 163
List of abbreviations 164
Glossary 166
Chapter 11: Indexes 171
Compliance index 172
Alphabetical index 176
LIST OF FIGURES
Figure 1: Australia’s anti-doping framework 19
Figure 2: Outcome and program structure 2012–13 21
Figure 3: Number of athletes and support personnel recording anti-doping rule violations 52
Figure 4: Organisational structure at 30 June 2013 57
LIST OF TABLES
Table 1: Program 1.1 qualitative deliverables 26
Table 2: Program 1.1 quantitative deliverables 27
Table 3: Program 1.1 qualitative key performance indicators 28
Table 4: Program 1.1 quantitative key performance indicators 29
Table 5: Education activities undertaken during 2012–13 37
Table 6: Satisfaction with ASADA education 39
Table 7: Anti-doping tests conducted by ASADA in 2012–13 46
Table 8: Doping control facts and figures 2012–13 47
Table 9: Substances involved in anti-doping matters 2012–13 51
Table 10: Breakdown of anti-doping rule violations 2012–13 52
Table 11: Expenditure on new and existing consultancy contracts 2012–13 71
Table 12: Trends in Consultancies 72
Table 13: Advisory Group attendance 2012–13 129
Table 14: Advisory Group expenses 2012–13 129
Table 15: ADRVP attendance 2012–13 133
Table 16: ADRVP expenses 2012–13 134
Table 17: ASDMAC members 141
Table 18: ASDMAC expenses 2012–13 142
Table 19: Therapeutic use exemptions granted 142
Table 20: Substances and methods approved for therapeutic use 2012–13 144
Table 21: ASDMAC freedom of information statistics 145
Table 22: Doping control statistics 148
Table 23: Publicly announced anti-doping rule violations 149
Table 24: Entries on Register of Findings 2011–12 where the outcomes were to be advised 150
Table 25: Government-to-government arrangements 151
Table 26: Full-time, part-time and casual staff at 30 June 2013 154
Table 27: Ongoing, non-ongoing and casual staff by classification groups and location at 30 June 2013 154
Table 28: SES staff at 30 June 2013 154
Table 29: Salary ranges of employees 155
Table 30: Number of staff in the collective agreement or section 24(1) determinations 155
Table 31: Advertising and market research 157
Table 32: ASADA freedom of information statistics 159
Table 33: Expenses for Outcome 1 160
Table 34: ASADA Resource Statement 2012–13 161

AUSTRALIAN SPORTS ANTI-DOPING AUTHORITY 2013:14 ANNUAL REPORT

TABLE OF CONTENTS
Letter of transmittal 3
About this report 4
Message from the CEO 10

Chapter 1: Organisational overview 17
About ASADA 18
Legislative basis 18
Purpose 19
Role and functions 19
Outcome and programme structure 20
Australia’s anti-doping structure 20
13-14 Achievements and highlights 22

Chapter 2: Report on performance 25
Programme 1.1 — Deterrence, detection and enforcement 26
Deliverables 26
Key performance indicators 28
Building awareness 30
Awareness-raising 30
Digital communications channels 30
Communication campaigns 31
Media 32
Printed resources 33
Searching the status of substances online 33
Telephone support 33
Education 35
Partnerships 36
Engagement 38
Assisting sporting organisations 38
International engagement 38
Detection 41
National testing and sport operations programme 42
Sample collection 42
Pure Performance programmes 42
User-pays tests 43
Long-term storage facility 43
Accreditation of DCOs and Chaperones 44
Intelligence 44
Investigations 45
Australian Federal Police review 45
Disclosure notices 45
Disclosure of protected customs information 46
Federal Court proceedings 46
Athlete whereabouts 46
Enforcement 47
Athlete counselling service 49

Chapter 3: Management and accountability 51
Corporate governance 52
Corporate and operational planning 52
Organisational structure and senior executive arrangements 52
Governance committees 54
Risk management 55
Ethical standards 56
Internal audits 57
Records management 57
Quality management 57
External scrutiny 59
Decisions and reports 59
Management of human resources 60
Workforce planning 60
Attraction and retention 60
Employment agreements 60
Section 24(1) determinations 61
Non-salary benefits 61
Performance pay 61
Australia Day medallion 61
Learning and development 62
Commonwealth Disability Strategy 62
Workplace health and safety 62

Chapter 4: Financial information 65
Summary of financial performance 2013–14 66
Asset management 66
Purchasing 67
Engagement of consultants and contractors 67
Consultants 67
Competitive tendering and contracting 68
Auditor-General access 68
Exempt contracts 68
Grant programmes 68

Chapter 5: Financial statements 71

Chapter 6: ASADA Advisory Group 125
Overview 126
Advisory Group members 126
Resources 127

Chapter 7: Anti‑Doping Rule Violation Panel 129
Overview 130
Functions 130
Members 130
Resources 133
Freedom of information — ADRVP 133

Chapter 8: Australian Sports Drug Medical Advisory Committee 135
Overview 136
Functions 136
Therapeutic approvals for prohibited substances 137
Members 137
Resources 139
Therapeutic Use Exemptions granted 139
Freedom of information — ASDMAC 141

Chapter 9: Appendixes 143
Appendix A: Doping control statistics 2001–02 to 2013–14 144
Appendix B: Publicly announced anti-doping rule violations 2013–14 145
Appendix C: International anti-doping arrangements 148
Appendix D: Powers of the Minister to give directions to the ASADA CEO 149
Appendix E: ASADA and CEO functions, powers and delegations 150
Appendix F: Staffing statistics at 30 June 2014 151
Appendix G: Workplace health and safety 153
Appendix H: Advertising and market research 154
Appendix I: Ecologically sustainable development and environmental performance 155
Appendix J: Expenses for Outcome 1 156
Appendix K: ASADA Resource Statement 2013–14 157
Appendix L: Correction of error in the 2012–13 Annual Report 158

Chapter 10: Abbreviations and glossary 161
List of abbreviations 162
Glossary 163
Chapter 11: Indexes 167
Compliance index 168
Alphabetical index 172

LIST OF FIGURES
Figure 1: Outcome and programme structure 2013–14 20
Figure 2: Australia’s anti-doping framework 21
Figure 3: Number of athletes and support personnel recording anti-doping rule violations 49
Figure 4: Organisational structure at 30 June 2014 53
LIST OF TABLES
Table 1: Programme 1.1 qualitative deliverables 26
Table 2: Programme 1.1 quantitative deliverables 27
Table 3: Programme 1.1 qualitative key performance indicators 28
Table 4: Programme 1.1 quantitative key performance indicators 29
Table 5: Education activities undertaken during 2013–14 36
Table 6: Satisfaction with ASADA education 38
Table 7: Anti-doping tests conducted by ASADA in 2013–14 43
Table 8: Doping control facts and figures 2013–14 44
Table 9: Disclosure Notices 46
Table 10: Substances involved in anti-doping matters 2013–14 48
Table 11: Breakdown of anti-doping rule violations 2013–14 48
Table 12: Expenditure on new and existing consultancy contracts 2013–14 67
Table 13: Trends in Consultancies 68
Table 14: Advisory Group attendance 2013–14 127
Table 15: Advisory Group expenses 2013–14 127
Table 16: ADRVP attendance 2013–14 133
Table 17: ADRVP expenses 2013–14 133
Table 18: ADRVP freedom of information statistics 133
Table 19: ASDMAC members 138
Table 20: ASDMAC expenses 2013–14 139
Table 21: 2013–14 Therapeutic Use Exemptions granted 139
Table 22: Substances and methods approved for therapeutic use 2013–14 141
Table 23: ASDMAC freedom of information statistics 141
Table 24: Doping control statistics 144
Table 25: Publicly announced anti-doping rule violations 145
Table 26: Entries on Register of Findings 2012–13 where the outcomes were to be advised 146
Table 27: Entries on Register of Findings 2011–12 where the outcomes were to be advised 147
Table 28: Government-to-government arrangements 148
Table 29: Full-time, part-time and casual staff at 30 June 2014 151
Table 30: Ongoing, non-ongoing and casual staff by classification groups and location at 30 June 2014 151
Table 31: SES staff at 30 June 2014 151
Table 32: Salary ranges of employees 152
Table 33: Number of staff in the collective agreement or section 24(1) determinations 152
Table 34: Advertising and market research 154
Table 35: Expenses for Outcome 1 156
Table 36: ASADA Resource Statement 2013–14 157

Australian Sports Anti-Doping Authority 2014:15 annual report / Australian Sports Anti-Doping Authority (ASADA). - Canberra : ASADA, 2015

Contents:

01: OVERVIEW
02: PERFORMANCE REPORTING
03: MANAGEMENT AND ACCOUNTABILITY
04: FINANCIAL INFORMATION
05: FINANCIAL STATEMENTS
06: ASADA ADVISORY GROUP
07: ANTI-DOPING RULE VIOLATION PANEL
08: AUSTRALIAN SPORTS DRUG MEDICAL ADVISORY COMMITTEE
09: APPENDIXES 165
10: ABBREVIATIONS AND GLOSSARY
11: INDEXES

Australian Sports Anti-Doping Authority 2015-16 annual report / Australian Sports Anti-Doping Authority (ASADA). - Canberra : ASADA, 2016

Contents:

01 OVERVIEW
02 ANNUAL PERFORMANCE STATEMENT
03 OUR OPERATIONS
04 MANAGEMENT AND ACCOUNTABILITY
05 FINANCIAL INFORMATION
06 FINANCIAL STATEMENTS
07 ANTI-DOPING RULE VIOLATION PANEL
08 AUSTRALIAN SPORTS DRUG MEDICAL ADVISORY COMMITTEE
09 APPENDIXES
10 ABBREVIATIONS AND GLOSSARY
11 INDEXES

Australian Sports Anti-Doping Authority 2016-17 annual report / Australian Sports Anti-Doping Authority (ASADA). - Canberra : ASADA, 2017

Contents:

01: OVERVIEW

02: ANNUAL PERFORMANCE STATEMENT

03: OUR OPERATIONS

04: MANAGEMENT AND ACCOUNTABILITY

05: FINANCIAL INFORMATION

06: FINANCIAL STATEMENTS

07: ANTI-DOPING RULE VIOLATION PANEL

08: AUSTRALIAN SPORTS DRUG MEDICAL ADVISORY COMMITTEE

09: APPENDIXES

10: ABBREVIATIONS AND GLOSSARY

11: INDEXES

Australian Sports Anti-Doping Authority 2017-18 annual report / Australian Sports Anti-Doping Authority (ASADA). - Canberra : ASADA, 2018

Contents:

01: OVERVIEW
02: ANNUAL PERFORMANCE STATEMENT
03: OUR OPERATIONS
04: 2018 COMMONWEALTH GAMES
05: MANAGEMENT AND ACCOUNTABILITY
06: FINANCIAL INFORMATION
07: FINANCIAL STATEMENTS
08: ANTI-DOPING RULE VIOLATION PANEL
09: AUSTRALIAN SPORTS DRUG MEDICAL ADVISORY COMMITTEE
10: APPENDIXES, ABBREVIATIONS, GLOSSARY
11: INDEXES